Among bromodomain and extra terminal (BET) proteins (BRD2, BRD3, BRD4), BRD4 has been strongly linked to cancer and inflammatory diseases, thereby representing an attractive target (Zengerle et al., 2015). The gene discussed is BRD4; the disease is cancer.